Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-83.26	16.73	99.91
Graham Fair Price	53.96	1236.89	803.37
PEG	-81.91	0.13	-0.72
Price/Book	-1.07	0.76	0.77
Price/Cash Flow	inf	0.00	16.83
Prices/Earnings	-56.67	17.31	39.94
Price/Sales	-4.03	0.80	0.83
Price/FCF	inf	0.00	16.83
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-3.68	0.28	0.29
Operating Margin	539.47	0.04	< 0.005
ROA	135.42	< 0.005	< 0.005
ROE	< 0.005	0.01	128.32
ROIC	< 0.005	0.02	629.18
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.02	0.03	-41.64
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.67	5.72	747.78
EPS QOQ	-0.55	1.33	139.48
FCF QOQ	0.07	-1.00	1367.21
Revenue QOQ	-0.04	0.05	40.19
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	23.10	20.09	-13.03
Days Sales Outstanding (DSO)	5.61	4.55	-18.96
Inventory Turnover	3.90	4.48	14.98
Debt/Capitalization	0.27	0.26	-5.62
Quick Ratio	0.30	0.36	20.62
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	2444.27	2490.55	1.89
Cash	333.14	429.05	28.79
Capex	0.00	0.00	0.00
Free Cash Flow	111.40	0.00	inf
Revenue	2263.48	2377.33	5.03
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	0.68	0.70	3.09
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	22.90	3.53	-84.57
Naive Interpretation	Member

06 - Financial Health · Bad

Rating